Treatment of migraine with substituted tropyl benzoate derivatives
US4563465A · kind A · utility
5Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 1984 |
| Grant date | Jan 7, 1986 |
| Priority date | — |
| Expiry date | Dec 13, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Migraine is treated with a tropyl benzoate derivative of the following general formula: ##STR1## wherein: R.sub.1 represents C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; PA0 R.sub.2 represents hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; and PA0 R.sub.3 represents hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen, provided that R.sub.3 is hydrogen when R.sub.2 is hydrogen, or a pharmaceutically acceptable salt thereof. Additionally, some novel tropyl benzoate derivatives are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.